Orkla ASA — M&A Activity 2021

Feb 14, 2021

Orkla acquires VitaePro and Oslo Skin Lab

Orkla acquires VitaePro and Oslo Skin Lab

Orkla Health has entered into an agreement to acquire 100% of the shares in

NutraQ 2 AS (NutraQ), which is a leading supplier of subscription-based health

and beauty products in the Nordic region.

NutraQ is behind the two well-known health and beauty concepts VitaePro and Oslo

Skin Lab. NutraQ also owns the two Men's Health brands Maxulin and Provexin, and

the Vesterålens Naturprodukter brand that offers omega-3 and various vitamin

supplements.

"With the acquisition of NutraQ, Orkla is taking a new, important step into a

growing health and wellness market. I am impressed by how NutraQ has adopted

subscription solutions to reach consumers directly in their own homes. NutraQ's

concepts and brands will offer Orkla exciting growth opportunities," says Orkla

President and CEO Jaan Ivar Semlitsch, adding:

"NutraQ will bring Orkla Health new competence, more sales channels and a larger

international scope of opportunity."

NutraQ was established in Norway in 2002 and has since also established

operations in Denmark, Finland and Sweden. These four countries account for

around 90% of turnover. The company is headquartered in Oslo, Norway, and

employs around 150 people. With its subscription-based business model, NutraQ

represents a new business approach for Orkla. The company currently has

approximately 410 000 active subscriptions and has experienced good growth in

the past few years. The number of active subscriptions has grown organically by

an average of 13% annually in the period 2018-2020.  The company's turnover

totalled NOK 862 million in 2020 and EBITDA of NOK 188 million.

"NutraQ has built up a business model and an organisation that is well

positioned for further growth and expansion. We think that, as a part of Orkla

Health, NutraQ will be able to launch a number of exciting concepts and

contribute to profitable growth in the coming years," says Hege Holter Brekke,

EVP and CEO of the Orkla Care business area, of which Orkla Health is a part. To

preserve NutraQ's individuality and special competence in direct-to-consumer

(D2C) sales, the company will be integrated as a stand-alone entity.

NutraQ is currently owned by the investment company Impilo and Sana Pharma

Holding. The parties have agreed on a purchase price that values NutraQ at NOK

3.1 billion at enterprise value.

The agreement is subject to the approval of the relevant competition

authorities.

Orkla Health is one of Scandinavia's leading branded consumer goods suppliers in

categories such as cod liver oil, vitamins and other dietary supplements. The

best-known brands in its portfolio are Möller's Tran, Nutrilett, Maxim, Livol,

Collett and Sana-sol.

Orkla is a leading supplier of branded consumer goods and concept solutions to

the consumer, out-of-home and bakery markets in the Nordics, Baltics and

selected markets in Central Europe and India. Orkla is listed on the Oslo Stock

Exchange and its headquarters is in Oslo. In 2020, the Group had a turnover of

NOK 47.1 billion, and just over 18,000 employees at year-end.

Orkla ASA

Oslo, 14 February 2021

Ref.:

Group Director Corporate Communications and Corporate Affairs

Håkon Mageli, mob.: +47 928 45 828

SVP Investor Relations

Kari Lindtvedt, mob.: +47 950 75 114

This information is subject to the disclosure requirements pursuant to Section 5

-12 the Norwegian Securities Trading Act